Capricor Therapeutics, Inc. CAPR
Set alert
7.24 USD +0.86 +13.48%
At close
7.20 -0.04 -0.55%
Pre-market · Nov 3, 6:26 AM ET
6.67 Day range 7.45
2.96 52-week range 40.37
- YTD
- -74.91%
- 1 year
- +19.28%
- Open
- 6.88
- Prev close
- 6.38
- Mkt cap
- 420.93M
- Vol
- 5.03M
- Avg vol
- 5.92M
- EPS
- -2.45
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 6.67
- High
- 7.45
- Forward P/E
- -35.03
- Beta
- 0.42
- Short ratio
- 13.95
- Inst. own
- 59.73%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 11, 2026
- 50-d avg
- 28.51
- 200-d avg
- 22.54
- 1y target
- 53.60
5D chart
Signals (106)
| Name | Time | Ago |
|---|---|---|
| MACD: Buy Signal | Nov 2, 3:50 PM | 14 hours ago |
| SMA: Bullish | Nov 2, 3:45 PM | 14 hours ago |
| MACD: Sell Signal | Nov 2, 3:35 PM | 14 hours ago |
| SMA: Bearish | Nov 2, 3:25 PM | 15 hours ago |
| RSI: Overbought | Nov 2, 3:20 PM | 15 hours ago |
| RSI: Overbought | Nov 2, 3:00 PM | 15 hours ago |
| MACD: Buy Signal | Nov 2, 2:35 PM | 15 hours ago |
| MACD: Sell Signal | Nov 2, 1:50 PM | 16 hours ago |
| SMA: Bearish | Nov 2, 1:40 PM | 16 hours ago |
| MACD: Buy Signal | Nov 2, 1:05 PM | 17 hours ago |
| SMA: Bullish | Nov 2, 12:55 PM | 17 hours ago |
| SMA: Bearish | Nov 2, 12:50 PM | 17 hours ago |
| SMA: Bearish | Nov 2, 11:40 AM | 18 hours ago |
| RSI: Overbought | Nov 2, 11:05 AM | 19 hours ago |
| MACD: Sell Signal | Nov 2, 10:50 AM | 19 hours ago |
| SMA: Bearish | Nov 2, 10:45 AM | 19 hours ago |
| RSI: Overbought | Nov 2, 9:30 AM | 20 hours ago |
| MACD: Buy Signal | Oct 30, 3:10 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 2:50 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:35 PM | 3 days ago |
Newest 20 of 106.
Financial health
Altman Z-Score
0.16 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 4
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 2
- P/E 1
- P/B 1
Valuation
P/E -12.8×
FY 2016 5y median -5.9× FY 2025
P/S 0.0×
FY 2016 5y median 21.8× FY 2025
P/B 4.4×
FY 2016 5y median 4.4× FY 2025
P/FCF -18.4×
FY 2016 5y median -4.7× FY 2025
EV/EBITDA -10.7×
FY 2016 5y median -5.7× FY 2025
EV/Sales 0.0×
FY 2016 5y median 21.5× FY 2025
FCF Yield -5.4%
FY 2016 5y median -8.5% FY 2025
Profitability
Gross Margin 0.0%
FY 2016 5y median -44.8% FY 2025
Operating Margin 0.0%
FY 2016 5y median -191.1% FY 2025
Net Margin 0.0%
FY 2016 5y median -181.7% FY 2025
ROE -34.4%
FY 2016 5y median -63.8% FY 2025
ROIC -33.4%
FY 2016 5y median -55.7% FY 2025
ROA -29.5%
FY 2016 5y median -37.9% FY 2025
Growth (YoY)
Revenue -100.0%
FY 2016 FY 2025
Operating Income -154.1%
FY 2016 FY 2025
EPS (diluted) -96.5%
FY 2016 FY 2025
Free Cash Flow -75.1%
FY 2016 FY 2025
Financial Health
Current Ratio 9.0×
FY 2016 5y median 7.8× FY 2025
Quick Ratio 9.0×
FY 2016 5y median 7.8× FY 2025
Debt / Equity 0.1×
FY 2016 5y median 0.2× FY 2025
Net Debt / EBITDA 2.7×
FY 2016 5y median 0.4× FY 2025
Interest Coverage -35.5×
FY 2016 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
